NexturnBioscience Co. Ltd (089140) - Total Liabilities

Latest as of September 2025: ₩128.65 Billion KRW ≈ $87.19 Million USD

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has total liabilities worth ₩128.65 Billion KRW (≈ $87.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 089140 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

NexturnBioscience Co. Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NexturnBioscience Co. Ltd assets under control.

NexturnBioscience Co. Ltd Competitors by Total Liabilities

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Yuyu Pharma Inc KO:000225	Korea	₩64.72 Billion
SDN Company. Ltd KQ:099220	Korea	₩83.71 Billion
T3 Defense Inc. NYSE:DFNS	USA	$98.39 Million
CEKD Bhd KLSE:0238	Malaysia	RM17.27 Million
Metro Bank PLC LSE:MTRO	UK	GBX15.73 Billion
Elicera Therapeutics AB ST:ELIC	Sweden	Skr6.97 Million
Air Industries Group NYSE MKT:AIRI	USA	$39.11 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down NexturnBioscience Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 089140 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.84	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NexturnBioscience Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual total liabilities of NexturnBioscience Co. Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩96.41 Billion ≈ $65.34 Million	-9.03%
2023-12-31	₩105.98 Billion ≈ $71.82 Million	+15.22%
2022-12-31	₩91.98 Billion ≈ $62.34 Million	+99.04%
2021-12-31	₩46.21 Billion ≈ $31.32 Million	+1689.03%
2020-12-31	₩2.58 Billion ≈ $1.75 Million	-48.45%
2019-12-31	₩5.01 Billion ≈ $3.40 Million	-72.17%
2018-12-31	₩18.01 Billion ≈ $12.20 Million	+502.69%
2017-12-31	₩2.99 Billion ≈ $2.02 Million	-65.43%
2016-12-31	₩8.64 Billion ≈ $5.86 Million	+172.72%
2015-12-31	₩3.17 Billion ≈ $2.15 Million	-28.10%
2014-12-31	₩4.41 Billion ≈ $2.99 Million	--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$14.67 Million

₩21.65 Billion KRW

Market Cap Rank

#26147 Global

#1965 in Korea

Share Price

₩2075.00

Change (1 day)

+0.00%

52-Week Range

₩1853.00 - ₩2995.00

All Time High

₩56500.00